Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
[1] [2] Research from the SURMOUNT clinical trials indicates that weight losswhich reflects sustained appetite suppressioncontinues through 72 weeks of treatment, with significant effects observed within the first few months
GLP-1 medications are best suited for individuals with a BMI of 30 or higher, or 27 and above with weight-related comorbidities like type 2 diabetes or high blood pressure
The difference shows up in where on the titration schedule each person finds their effective maintenance dose
Tirzepatide activates two separate appetite-control pathways in your brainthe GLP-1 receptor and the GIP receptorworking faster than single-pathway medications
2025] Muller, D.R.P., Stenvers, D.J., Malekzadeh, A., Holleman, F., Painter, R.C., Siegelaar, S.E., 2023
US$ 25.32
US$ 24.95
US$ 25.89
US$ 21.30
US$ 24.38
US$ 29.19
